Using an experimental approach to modeling Alzheimer’s disease, new molecular mechanisms of the dysregulation of insulin signaling in the amygdala in connection with the processes of neuroinflammation were investigated (Figure 12). This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.